Susquehanna International Group
YARW

Susquehanna International Group’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Susquehanna International Group’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed -$91K – 13339
2021
Q1 		$91K Buy
+15
New +$109K ﹤0.01% 11892
2020
Q2 		– Sell
-10
Closed -$97K – 11022
2020
Q1 		$97K Buy
+10
New +$157K ﹤0.01% 9345

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group's YARW Position: Q1 2026 in Review

Susquehanna International Group reduced its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 42% in Q1 2026, selling an estimated $24.8K and leaving 1,156 shares worth $34.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12729.

Susquehanna International Group first reported a position in YARW in Q1 2020 and has held it in 22 quarters since. The position peaked at $310K in Q2 2023. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Susquehanna International Group held 1,156 shares of Yarrow Bioscience, Inc. Common Stock worth $34.5K as of Q1 2026.
  • Susquehanna International Group sold 851 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $24.8K.
  • Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12729 holding.
  • Susquehanna International Group first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and has held it in 22 quarters since.
  • Susquehanna International Group's Yarrow Bioscience, Inc. Common Stock position peaked at $310K in Q2 2023.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.